A panel of CEOs will discuss the most pressing issues facing blood centers over the next five years, and how data and research can help address those issues. The panel discussion will be followed by administrative oral abstracts and a questions-and-answer period.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM23-SN-22-O: CEO Panel Abstract Spotlight (Enduring) Evaluation